Why This Drugmaker’s Earnings Guidance Cut Doesn’t Tell the Full Story
Yahoo Finance
Read Full Article at Yahoo Finance →Ad Slot — In-Article (728x90)
Biogen’s growth portfolio, which includes one closely watched Alzheimer’s drug, is a bright spot in the second quarter.
This is a summary. For the full story, read the original article at Yahoo Finance.
Original source: Yahoo Finance